 IAB2M is an approximately 80 kDA molecular weight antibody fragment a Minibody chelated with Desferroxamine and radiolabeled with 89Zr. 89Zr-Df-IAB2M targets the extracellular domain of Prostate Membrane Specific Antigen PSMA expressed on most primary and metastatic prostate cancer lesions. 